0000899243-19-015996.txt : 20190607
0000899243-19-015996.hdr.sgml : 20190607
20190607161523
ACCESSION NUMBER: 0000899243-19-015996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190605
FILED AS OF DATE: 20190607
DATE AS OF CHANGE: 20190607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrett Peter
CENTRAL INDEX KEY: 0001291895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 19885896
MAIL ADDRESS:
STREET 1: C/O ALNYLAM PHARMACEUTICALS, INC.
STREET 2: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-05
0
0001527599
SYNLOGIC, INC.
SYBX
0001291895
Barrett Peter
C/O SYNLOGIC, INC.
301 BINNEY STREET, SUITE 402
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
7.30
2019-06-05
4
A
0
10000
0.00
A
2029-06-05
Common Stock
10000
10000
D
The option vests and becomes exercisable in full on the earlier of (A) the first anniversary of the date of grant or (B) immediately prior to the next annual meeting of the Corporation's stockholders after the date of grant, subject in each case to each non-employee director's continued service as a director of the Corporation.
The reporting person is a member of Atlas Venture Associates IX, LLC ("AVA IX LLC") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to Atlas Venture Advisors, L.P. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
/s/ William J. Bussiere, Jr., Attorney-in-fact
2019-06-07